Delcath Systems, Inc. (NASDAQ:DCTH) insiders who purchased shares in the last 12 months were richly rewarded last week. The stock climbed by 16% resulting in a US$37m addition to the company’s market value. As a result, the stock they originally bought for US$540.9k is now worth US$1.94m.
While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.
See our latest analysis for Delcath Systems
In the last twelve months, the biggest single purchase by an insider was when Chief Medical Officer Vojislav Vukovic bought US$149k worth of shares at a price of US$2.48 per share. We do like to see buying, but this purchase was made at well below the current price of US$9.51. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.
While Delcath Systems insiders bought shares during the last year, they didn't sell. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!
Delcath Systems is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. Our data indicates that Delcath Systems insiders own about US$7.2m worth of shares (which is 2.7% of the company). Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!
There haven't been any insider transactions in the last three months -- that doesn't mean much. However, our analysis of transactions over the last year is heartening. The transactions are fine but it'd be more encouraging if Delcath Systems insiders bought more shares in the company. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. Be aware that Delcath Systems is showing 2 warning signs in our investment analysis, and 1 of those is potentially serious...
Of course Delcath Systems may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.